Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1795 1
1805 1
1806 1
1807 1
1810 1
1811 1
1819 1
1820 1
1830 1
1835 1
1840 1
1841 1
1842 4
1843 2
1844 2
1847 3
1848 6
1849 6
1850 3
1851 3
1852 4
1853 6
1855 2
1857 1
1858 3
1859 1
1861 1
1862 1
1864 1
1865 1
1866 2
1868 1
1869 1
1871 3
1873 3
1875 6
1876 1
1877 2
1878 3
1879 4
1880 5
1881 5
1882 1
1883 1
1884 2
1885 4
1886 3
1887 5
1888 1
1889 1
1890 4
1891 7
1892 3
1893 3
1894 6
1895 3
1896 8
1897 7
1898 8
1899 8
1900 4
1901 5
1902 8
1903 1
1904 3
1905 7
1906 9
1907 13
1908 17
1909 19
1910 13
1911 19
1912 20
1913 18
1914 24
1915 26
1916 32
1917 33
1918 29
1919 29
1920 44
1921 53
1922 58
1923 54
1924 60
1925 44
1926 47
1927 78
1928 55
1929 56
1930 50
1931 52
1932 51
1933 47
1934 39
1935 48
1936 39
1937 37
1938 45
1939 40
1940 47
1941 54
1942 34
1943 28
1944 40
1945 124
1946 244
1947 373
1948 378
1949 292
1950 354
1951 457
1952 386
1953 421
1954 445
1955 471
1956 425
1957 425
1958 455
1959 465
1960 497
1961 561
1962 613
1963 821
1964 1067
1965 1152
1966 1509
1967 1587
1968 1868
1969 1918
1970 1964
1971 2090
1972 2151
1973 2253
1974 2253
1975 4837
1976 4810
1977 4544
1978 4611
1979 4942
1980 5038
1981 5246
1982 5589
1983 6220
1984 6989
1985 7078
1986 7259
1987 7531
1988 8076
1989 9649
1990 9849
1991 10011
1992 10211
1993 10397
1994 10856
1995 10962
1996 11745
1997 11784
1998 12463
1999 13180
2000 14697
2001 16132
2002 17118
2003 18091
2004 21132
2005 24371
2006 26378
2007 27210
2008 28595
2009 29700
2010 31541
2011 33111
2012 34952
2013 36908
2014 38994
2015 40353
2016 41350
2017 43377
2018 47139
2019 49754
2020 56328
2021 61566
2022 63202
2023 63051
2024 23336

Text availability

Article attribute

Article type

Publication date

Search Results

1,026,336 results

Results by year

Filters applied: . Clear all
Page 1
Biocompatible dialysis fluids for peritoneal dialysis.
Htay H, Johnson DW, Wiggins KJ, Badve SV, Craig JC, Strippoli GF, Cho Y. Htay H, et al. Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3. Cochrane Database Syst Rev. 2018. PMID: 30362116 Free PMC article.
OBJECTIVES: This review aimed to look at the benefits and harms of biocompatible PD solutions in comparison to standard PD solutions in patients receiving PD. ...Overall, 29 studies (1971 participants) compared neutral pH, low GDP PD solution with conventiona …
OBJECTIVES: This review aimed to look at the benefits and harms of biocompatible PD solutions in comparison to standard PD solutio
Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.
Raut AS, Kalonia DS. Raut AS, et al. Mol Pharm. 2016 May 2;13(5):1431-44. doi: 10.1021/acs.molpharmaceut.5b00937. Epub 2016 Apr 5. Mol Pharm. 2016. PMID: 27017836 Review.
Opalescence in protein solutions reduces aesthetic appeal of a formulation and can be an indicator of the presence of aggregates or precursor to phase separation in solution signifying reduced product stability. ...The review also highlights pharmaceutical im …
Opalescence in protein solutions reduces aesthetic appeal of a formulation and can be an indicator of the presence of aggregates or p …
Formulation and Stability of Solutions.
Akers MJ. Akers MJ. Int J Pharm Compd. 2016 Mar-Apr;20(2):137-41. Int J Pharm Compd. 2016. PMID: 27326440
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs formulated as solution almost always have chemical and physical stability challenges as well as solubility limitations and the need to p …
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs for …
Critical factors influencing the in vivo performance of long-acting lipophilic solutions--impact on in vitro release method design.
Weng Larsen S, Larsen C. Weng Larsen S, et al. AAPS J. 2009 Dec;11(4):762-70. doi: 10.1208/s12248-009-9153-9. Epub 2009 Nov 6. AAPS J. 2009. PMID: 19894123 Free PMC article. Review.
Parenteral long-acting lipophilic solutions have been used for decades and might in the future be used in the design of depots with tailored delivery characteristics. The present review highlights major factors influencing the in vivo performance of lipophilic solutions
Parenteral long-acting lipophilic solutions have been used for decades and might in the future be used in the design of depots with t …
Electrospraying of polymer solutions: Study of formulation and process parameters.
Smeets A, Clasen C, Van den Mooter G. Smeets A, et al. Eur J Pharm Biopharm. 2017 Oct;119:114-124. doi: 10.1016/j.ejpb.2017.06.010. Epub 2017 Jun 10. Eur J Pharm Biopharm. 2017. PMID: 28610878
Based on this, the type of solvent and the concentration of the polymer solutions, along with their viscosity and conductivity, were identified as determinative formulation parameters. ...
Based on this, the type of solvent and the concentration of the polymer solutions, along with their viscosity and conductivity, were …
[Injection solutions].
DELTOMBE J. DELTOMBE J. Ann Belg Med Mil. 1951 Jul-Aug;104(5):183-7. Ann Belg Med Mil. 1951. PMID: 14868921 Undetermined Language. No abstract available.
Stability of ceftiofur sodium and cefquinome sulphate in intravenous solutions.
Dołhań A, Jelińska A, Bębenek M. Dołhań A, et al. ScientificWorldJournal. 2014;2014:583461. doi: 10.1155/2014/583461. Epub 2014 Jun 3. ScientificWorldJournal. 2014. PMID: 25025091 Free PMC article.
During the stability study, poly(vinylchloride) minibags were filled with a solution containing 5 mg of ceftiofur sodium or cefquinome sulphate and diluted to 0.2 mg/mL with suitable intravenous solution depending on the test conditions. ...A comparison of results o …
During the stability study, poly(vinylchloride) minibags were filled with a solution containing 5 mg of ceftiofur sodium or cefquinom …
Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer.
Kawedia JD, Zhang YP, Myers AL, Richards-Kortum RR, Kramer MA, Gillenwater AM, Culotta KS. Kawedia JD, et al. J Oncol Pharm Pract. 2016 Feb;22(1):21-5. doi: 10.1177/1078155214546564. Epub 2014 Aug 10. J Oncol Pharm Pract. 2016. PMID: 25113309
Solutions stored at room temperature were chemically stable up to six months (94-105%). ...The solution was chemically stable for six months when stored at room temperature. ...
Solutions stored at room temperature were chemically stable up to six months (94-105%). ...The solution was chemically stable
1,026,336 results
You have reached the last available page of results. Please see the User Guide for more information.